The RightAI platform aims to assist clinicians in selecting the right patients for clinical trials and make precise treatment ...

A partial hold was placed on the trial after results showed variance between squamous and non-squamous NSCLC patient ...

Nurix Therapeutics has reported positive clinical data from its ongoing Phase Ia/Ib trial of NX-5948 for Waldenstrom's ...

Vabysmo is the first drug of its kind to receive approval for diabetic macular oedema treatment. Credit: Prostock-studio / ...

RZ-402 has the potential to treat or prevent DME, and influence both clinical practice and patient burden experienced by DME ...